Not a single study
Story checked
Do I have asthma? All you need to know about symptoms, diagnosis and treatments (opens in a new tab)
medicalxpress.com · 2026-09-08
Short answer
Not a single studyNo clear answer.
The article covers a research area rather than reporting a specific new paper, so there is no single study to check it against.
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
Do I have asthma? All you need to know about symptoms, diagnosis and treatments
medicalxpress.com · 2026-09-08
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
This story isn't reporting one study.
The article covers a research area rather than reporting a specific new paper, so there is no single study to check it against.
Open claim evidenceSearch result
No single source study.
The article covers a research area rather than reporting a specific new paper, so there is no single study to check it against.
Evidence layer
Claim by claim
What the story asserts. With no source study, there is nothing to check these against.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 6Not checkedAsthma is a long-term chronic inflammatory disease of the airways that can cause chest tightness, cough, wheezing, and reduced airflow.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 2 of 6Not checkedAsthma has different phenotypes, including common type 2-high allergic and/or eosinophilic asthma and type 2-low asthma.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 3 of 6Not checkedAsthma is usually diagnosed through history and physical examination, with spirometry, skin testing, blood work, and fractional exhaled nitric oxide used to help classify and manage it.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 4 of 6Not checkedCommon asthma triggers include allergens, viral respiratory infections, exercise, weather changes, smoke, stress, obesity, and some medications such as aspirin.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 5 of 6Not checkedAsthma treatment depends on type and severity, but commonly includes inhalers, inhaled corticosteroids, bronchodilators, oral medications, and biologics for moderate-to-severe disease.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 6 of 6Not checkedIf asthma is not properly treated, it can progress to airway remodeling and lasting narrowing and stiffness of the airways, but early therapy and good symptom control can help prevent this.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Method layer
No single source study was found.
NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.
Nearby research
No exact source, but these papers are close.
PubMed, Europe PMC, Crossref · 15 candidate papers
Asthma in Older Adults: Clinical Patterns, Inflammatory Phenotypes, and Practical Management.
The Journal of Allergy and Clinical Immunology. in Practice · 2026 · PubMed, Europe PMC
Unveiling the Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Diagnosis and Inflammatory Phenotyping: A Dissociation from Lung Function and Asthma Control
2024 · Crossref
[The key role of chest CT in severe asthma phenotyping].
2026 · Europe PMC
Phenotypes and endotypes of cough in asthma.
Therapeutic Advances in Respiratory Disease · 2026 · PubMed
Correlation of Fractional Exhaled Nitric Oxide [Feno], Spirometry, and Symptom Control in Childhood Asthma, A Cross-Sectional Study
Journal of Chemical Health Risks · 2024 · Crossref
And 10 more candidates considered.